Magnus Financial Group LLC Oncolytics Biotech Inc Transaction History

Magnus Financial Group LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 28, 2020	SELL	$0.42 - $4.76 $10,500 - $119,000	-25,000 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$0.54 - $1.71 $8,100 - $25,650	15,000 Added 150.0%	25,000 $14,000
Q2 2019 Aug 05, 2019	BUY	$1.63 - $1.95 $16,299 - $19,500	10,000 New	10,000 $17,000

1.24M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $45.7M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Magnus Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Magnus Financial Group LLC with notifications on news.